ImmPACT Bio USA names new chief medical officer
14 September 2022 -

ImmPACT Bio USA, Inc, a clinical-stage company, announced on Tuesday that it has named Jonathan Benjamin, MD, Ph.D. as its chief medical officer.

In the new role, Dr Benjamin is to head the company's clinical development strategy.

Dr Benjamin has served as senior vice president for clinical research at Atreca, Inc and medical director at Amgen Inc. He has also served as an assistant professor of medicine in the Division of Blood and Marrow Transplant at Stanford University School of Medicine.